首页> 中文期刊> 《中国生化药物杂志》 >药物干预与认知干预在慢性阻塞性肺疾病(COPD)患者中的应用

药物干预与认知干预在慢性阻塞性肺疾病(COPD)患者中的应用

         

摘要

目的 探讨认知干预与药物干预在慢性阻塞性肺疾病(COPD)患者中的应用.方法 随机将2016年2月~2016年7月收治的慢性阻塞性肺疾病患者86 例纳入本次研究,根据患者的入院顺序分为实验组和对照组,对照组43 例患者接受常规措施,实验组43 例患者接受认知干预与药物干预,对比实验组与对照组患者干预后的临床治疗效果与治疗依从性.结果 实验组中患者的疾病认知、吸烟、遵医用药、肺功能检查、家庭氧疗、呼吸锻炼、康复治疗、营养支持、流感疫苗接种的依从率均显著优于对照组( P< 0.05);干预后实验组感冒次数为(1.2±0.7)次、急性发作次数为(2.0±0.8)次、生存质量为(4.4±0.9)分,均显著优于对照组( P< 0.05).结论 认知干预与药物干预对慢性阻塞性肺疾病患者治疗依从性具有积极影响,提高患者的生存质量.%Objective To explore the application of cognitive intervention and drug intervention in patients with chronic obstructive pulmonary disease(COPD).Methods A total of 86 patients with chronic obstructive pulmonary disease(COPD)admitted from February 2016 to July 2016 were included in this study.The patients were divided into experimental group and control group according to the order of admission.43 patients in the control group received routine measures,In the experimental group,43 patients received cognitive intervention and drug intervention,compared the clinical treatment effect and treatment compliance of the two groups after intervention.Results The compliance rate of disease cognition,smoking,medication,pulmonary function,family oxygen therapy,respiration exercise,rehabilitation therapy,nutritional support and influenza vaccination were significantly better in the experimental group than in the control group(P<0.05)(1.2±0.7)times,the number of acute attack was(2.0±0.8)times and the quality of life was(4.4±0.9)points,which was significantly better than that of the control group(P<0.05).Conclusion Cognitive intervention and drug intervention have a positive effect on the treatment compliance of patients with chronic obstructive pulmonary disease,improve the quality of life of patients,and have significant clinical application value.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号